FDA Yanks Ranbaxy's Approvals For Generic Nexium, Valcyte
The U.S. Food and Drug Administration on Thursday announced it has rescinded tentative approvals given to India-based Ranbaxy Laboratories Ltd. for generic versions of AstraZeneca PLC's Nexium and Genentech Inc.'s Valcyte,...To view the full article, register now.
Already a subscriber? Click here to view full article